IBRX
$9.18-8.20%
as of close, Oct 16, 2026
☾ AH $9.18 -8.20%
ImmunityBio Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.02%Russell 3000 0.005%US Stock Market 0.004%
IBRX — ImmunityBio Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEE
5.010.015.020.025.030.035.00500.0M$9.18—20162019202120242026
2026-10-16
Price$9.18
MA20$8.13
MA50$5.93
Vol113.0M
Key stats#
Price data
- Price
- $9.18
- YTD price return
- +363.64%
- YTD total return
- +363.64%
- Next earnings
- Nov 3, 2026
- Market cap
- 9.7B
- Enterprise value
- 9.4B
- Shares outstanding
- 1.1B
- 52W low
- $1.95
- 52W high
- $12.43
- From 52W high
- -26.15%
- From 52W low
- +370.77%
- 52W range
- 69%
Volume
- Rel volume
- 1.50×
- 30D volume
- 14.3M
- 30D $ vol
- 132M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$1.1M
- Insider net 3M
- −$1.1M
- Insider net 1Y
- −$9.5M
Form 4 transactions by trade date, as filed; latest on file 2026-10-05.
Fundamentals
- Sales (ttm)
- 165.8M
- Sales/share
- $0.16
- EPS (ttm)
- -$0.99
- FCF (ttm)
- -288.1M
- FCF/share
- -$0.27
- Book value/share
- -$0.99
- Net margin
- -598.56%
- ROA
- -157.89%
- Current ratio
- 5.72
Growth (CAGR, ttm) · 10Y
- Sales
- +193.13%+553.98%+202.97%+128.38%
- Shares
- +12.13%+32.43%+22.06%+29.12%
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +161.42%+393.83%+148.20%+76.87%
- Price
- +263.17%+87.59%-0.26%+3.34%
- Total return
- +263.17%+87.59%-0.26%+3.34%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -9.3×
- Fwd P/E
- -70.0×
- P/S (ttm)
- 58.7×
- P/B (mrq)
- -9.3×
- EV/Sales (ttm)
- 56.8×
- FCF yield (ttm)
- -2.96%
- Buyback yield (realized, 1y)
- -12.13%
- Shareholder yield (realized, 1y)
- -12.13%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 11th
- P/B
- 99th
Bar = where today’s multiple sits in IBRX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-16#
1D
-8.20%
5D
-12.65%
1M
+16.06%
3M
+23.22%
YTD
+363.64%
1Y
+262.85%
5Y
-1.29%
Recent filings#
All filings and insider trades →Financial statements
Open full IBRX financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +10.48% | +0.43% |
| JNJ | Johnson & Johnson | -4.38% | +0.90% |
| ABBV | AbbVie Inc. | +8.73% | +0.71% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +6.97% | -1.29% |
| MRK | Merck & Co. Inc. | +0.72% | +0.52% |
| NVS | Novartis AG | +8.59% | +0.16% |
| TMO | Thermo Fisher Scientific Inc. | +6.41% | -0.93% |
| AMGN | Amgen Inc. | +14.92% | -0.35% |
